WAKIX Gets Additional FDA Approval—for Cataplexy
FDA approval of WAKIX for the treatment of cataplexy in adult patients with narcolepsy is based on two randomized, controlled trials.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
